Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: Effect of spray drying process conditions on aerosol performance

International Journal of Pharmaceutics

Volumn 443, Issue 1-2, 2013, Pages 137-145

  Son, Yoen Ju ^a   Worth Longest, P ^a,b   Hindle, Michael ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Virginia Commonwealth University   (United States)

Author keywords

Dry powder inhaler; Excipient enhanced growth (EEG); Hygroscopic aerosol; Spray drying; Vibrating mesh

Indexed keywords

EXCIPIENT; EXCIPIENT ENHANCED GROWTH; LEUCINE; MANNITOL; POLOXAMER; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; DISPERSION; DRUG FORMULATION; DRY POWDER; IN VITRO STUDY; POWDER INHALER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRY POWDER INHALERS; EQUIPMENT DESIGN; EXCIPIENTS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANATOMIC; MOUTH; PARTICLE SIZE; PHARYNX; POWDERS; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84873048683     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.003     Document Type: Article

References (46)

1. I. Ashurst, A. Malton, D. Prime, and B. Sumby Latest advances in the development of dry powder inhalers Pharm. Sci. Technol. Today 3 2000 246 256
2. L. Borgstrom, E. Bondesson, F. Moren, E. Trofast, and S.P. Newman Lung deposition of budesonide inhaled via Turbuhaler-a comparision with terbutaline sulfate in normal subjects Eur. Respir. J. 7 1994 69 73
3. P. Brand, T. Meyer, T. Weuthen, W. Timmer, E. Berkel, G. Wallenstein, and G. Scheuch Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease J. Clin. Pharmacol. 47 2007 1335 1341
4. Y.S. Cheng Aerosol deposition in the extrathoracic region Aerosol Sci. Technol. 37 2003 659 671
5. A.H.L. Chow, H.H.Y. Tong, P. Chattopadhyay, and B.Y. Shekunov Particle engineering for pulmonary drug delivery Pharm. Res. 24 2007 411 437
6. R.R. Delvadia, P.W. Longest, and P.R. Byron In vitro tests for aerosol deposition. I: scaling a physical model of the upper airways to predict drug deposition variation in normal humans J. Aerosol Med. Pulm. Drug Deliv. 25 2012 32 40
7. D. Deshpande, J. Blanchard, S. Srinivasan, D. Fairbanks, J. Fujimoto, T. Sawa, J. Wiener-Kronish, H. Schreier, and I. Gonda Aerosolization of lipoplexes using AERx pulmonary delivery system AAPS PharmSci 4 2002 1 10
8. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. BenJebria, M.L. Eskew, J. Mintzes, D. Deaver, N. Lotan, and R. Langer Large porous particles for pulmonary drug delivery Science 276 1997 1868 1871
9. D. Geldart Types of gas fluidization Powder Technol. 7 1973 285 292
10. D.E. Geller, J. Weers, and S. Heuerding Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere (TM) technology J. Aerosol Med. Pulm. Drug Deliv. 24 2011 175 182
11. T. Ghazanfari, A.M.A. Elhissi, Z. Ding, and K.M.G. Taylor The influence of fluid physicochemical properties on vibrating-mesh nebulization Int. J. Pharm. 339 2007 103 111
12. N.J. Harper, S. Gray, J. De Groot, J.M. Parker, N. Sadrzadeh, C. Schuler, J.D. Schumacher, S. Seshadri, A.E. Smith, G.S. Steeno, C.L. Stevenson, R. Taniere, M. Wang, and D.B. Bennett The design and performance of the Exubera((R)) pulmonary insulin delivery system Diabetes Technol. Ther. 9 2007 S16 S27
13. M. Hindle, and P.W. Longest Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device J. Pharm. Pharmacol. 64 2012 1254 1263
14. M. Hindle, and G. Makinen Effects of humidity on the in-vitro aerosol performance and aerodynamic size distribution of cromolyn sodium for inhalation Eur. J. Pharm. Sci. 4 1996 S142
15. W.L. Hulse, R.T. Forbes, M.C. Bonner, and M. Getrost The characterization and comparison of spray-dried mannitol samples Drug Dev. Ind. Pharm. 35 2009 712 718
16. N. Islam, and E. Gladki Dry powder inhalers (DPIs)-a review of device reliability and innovation Int. J. Pharm. 360 2008 1 11
17. P.A. Jaques, and C.S. Kim Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women Inhal. Toxicol. 12 2000 715 731
18. S.H. Lee, D. Heng, W.K. Ng, H.K. Chan, and R.B.H. Tan Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy Int. J. Pharm. 403 2011 192 200
19. Y.-Y. Lee, J.X. Wu, M. Yang, P.M. Young, F. van den Berg, and J. Rantanen Particle size dependence of polymorphism in spray-dried mannitol Eur. J. Pharm. Sci. 44 2011 41 48
20. X.A. Li, N. Anton, C. Arpagaus, F. Belleteix, and T.F. Vandanune Nanoparticles by spray drying using innovative new technology: the Buchi Nano Spray Dryer B-90 J. Control. Release 147 2010 304 310
21. P.W. Longest, and M. Hindle Numerical Model to Characterize the Size Increase of Combination Drug and Hygroscopic Excipient Nanoparticle Aerosols Aerosol Science and Technology 45 2011 884 899
22. P.W. Longest, G. Tian, X. Li, Y.-J. Son, and M. Hindle Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways Ann. Biomed. Eng. 2012 10.1007/s10439-10012-06160-10432
23. P.W. Longest, G. Tian, Y.-J. Son, X. Li, and M. Hindle Engineered Drug Targeting to the Lungs: Ensuring Growth and Deposition of Submicrometer Aerosols through Device Design and Formulations, Respiratory Drug Delivery 2012 2012 Davis Healthcare International River Grove, IL pp. 61-69
24. S.P. Newman, and W.W. Busse Evolution of dry powder inhaler design, formulation, and performance Respir. Med. 96 2002 293 304
25. S.P. Newman, G.R. Pitcairn, P.H. Hirst, R.E. Bacon, E. O'Keefe, M. Reiners, and R. Hermann Scintigraphic comparison of budesonide deposition from two dry powder inhalers Eur. Respir. J. 16 2000 178 183
26. D. Prime, P.J. Atkins, A. Slater, and B. Sumby Review of dry powder inhalers Adv. Drug Deliv. Rev. 26 1997 51 58
27. J. Raula, A. Laehde, and E.I. Kauppinen A novel gas phase method for the combined synthesis and coating of pharmaceutical particles Pharm. Res. 25 2008 242 245
28. J. Raula, F. Thielmann, M. Naderi, V.P. Lehto, and E.I. Kauppinen Investigations on particle surface characteristics vs. dispersion behaviour of l-leucine coated carrier-free inhalable powders Int. J. Pharm. 385 2010 79 85
29. J. Rosell, J. Schuster, I. Gonda, and K. Liu Electrostatic charge in AERx aerosols Drug Delivery to the Lungs XI 2000 The Aerosol Society Bristol, U.K 64-67
30. K. Schmid, C. Arpagaus, and W. Friess Evaluation of the nano spray dryer B-90 for pharmaceutical applications Pharm. Dev. Technol. 16 2010 287 294
31. G. Tian, P.W. Longest, G. Su, and M. Hindle Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways Ann. Biomed. Eng. 39 2011 1136 1153
32. G. Tian, P.W. Longest, G. Su, R.L. Walenga, and M. Hindle Development of a stochastic individual path (SIP) model for predicting the tracheobronchial deposition of pharmaceutical aerosols: effects of transient inhalation and sampling the airways J. Aerosol Sci. 42 2011 781 799
33. M.P. Timsina, G.P. Martin, C. Marriott, D. Ganderton, and M. Yianneskis Drug-delivery to the respiratory-tract using dry powder inhalers Int. J. Pharm. 101 1994 1 13
34. R. Vehring Pharmaceutical particle engineering via spray drying Pharm. Res. 25 2008 999 1022
35. J. Visser Van der Waals and other cohesive forces affecting powder fluidization Powder Technol. 58 1989 1 10
36. G.H. Ward, and R.K. Schultz Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability Pharm. Res. 12 1995 773 779
37. J.G. Weers, T.E. Tarara, and A.R. Clark Design of fine particles for pulmonary drug delivery Expert Opin. Drug Deliv. 4 2007 297 313
38. J. Xi, and P.W. Longest Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway Ann. Biomed. Eng. 35 2007 560 581
39. J. Xi, and P.W. Longest Effects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticles J. Biomech. Eng. 130 2008 011008
40. W. Yang, J.I. Peters, and R.O. Williams III Inhaled nanoparticles-a current review Int. J. Pharm. 356 2008 239 247
41. Y. You, M. Zhao, G. Liu, and X. Tang Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method J. Pharm. Pharmacol. 59 2007 927 934
42. P.M. Young, A. Sung, D. Traini, P. Kwok, H. Chiou, and H.K. Chan Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems Pharm. Res. 24 2007 963 970
43. L. Yu, D.S. Mishra, and D.R. Rigsbee Determination of the glass properties of d-mannitol using sorbitol as an impurity J. Pharm. Sci. 87 1998 774 777
44. P. Zanen, P.I. van Spiegel, H. van der Kolk, E. Tushuizen, and R. Enthoven The effect of the inhalation flow on the performance of a dry powder inhalation system Int. J. Pharm. 81 1992 199 203
45. Y. Zhang, K. Gilbertson, and W.H. Finlay In vivo-in vitro comparison of deposition in three mouth-throat models with Qvar (R) and Turbuhaler (R) inhalers J. Aerosol Med. 20 2007 227 235
46. Q.T. Zhou, B. Armstrong, I. Larson, P.J. Stewart, and D.A.V. Morton Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders Eur. J. Pharm. Sci. 40 2010 412 421